Anti-HIV-1 activity and structure-activity relationship of cepharanoline derivatives in chronically infected cells

Antiviral Chemistry and Chemotherapy

Volumn 12, Issue 5, 2001, Pages 307-312

  Baba, M ^a   Okamoto, M ^a   Kashiwaba, N ^a   Ono, M ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Alkaloid; Cepharanthine; Chronic infection; HIV 1; Structure activity relationship; U1 cells

Indexed keywords

12 O ETHYLPIPERAZINYLCEPHARANOLINE; ALKALOID; ALKYL GROUP; CEPHARANOLINE DERIVATIVE; CEPHARANTHINE; FUNCTIONAL GROUP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRAL GENETICS; VIRUS REPLICATION;

EID: 0035718925     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020101200506     Document Type: Article

References (20)

1. Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives
2. Cellular factors as targets for anti-human immunodeficiency virus therapy
3. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanism of latency
4. Therapeutic targeting of human immunodeficiency virus type-1 latency: Current clinical realities and future scientific possibilities
5. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line
6. Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms
7. Cytokine induced expression of HIV-1 in a chronically infected promonocytic cell line
8. Activation of HIV gene expression during monocyte differentiation by induction of NFKB
9. Cepharanthine (biscoclaurine alkaloid) treatment in endotoxic shock of suckling rats
10. Selective inhibition of T-cell dependent immune responses by bisbenzylisoquinoline alkaloids in vivo
11. Inhibition of active oxygen generation in guinea-pig neutrophils by biscoclaurine alkaloids
12. HIV-1, macrophages, grial cells, and cytokines in AIDS nervous system disease
13. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
14. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid cepharanthine in chronically infected monocytic cells
15. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells
16. Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: A potential agent against HIV-1 encephalopathy
17. Tumor necrosis factor and interleukin 1 stimulate the human immunodericiency virus enhancer by activation of the nuclear factor κB
18. Rapid and automated tertazolium-based colorimetric assay for detection of anti-HIV compounds
19. Mutations in retroviral genes associated with drug resistance: 2000-2001 update
20. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-α